Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1088 blog entries.

May 2024

Conversation with Jukka Tapaninen, CEO at Aiforia Technologies

2026-10-06T08:47:17+00:00

This interview with Jukka Tapaninen, CEO of Aiforia Technologies, explores his career journey and how he came to lead Aiforia, a pioneer in digital pathology. Jukka discusses Aiforia's development, including the company's transition to AI-based pathology solutions and their expansion into clinical applications. He highlights the company's focus on AI for image analysis, the importance of collaboration with other platforms, and the competitive landscape. The interview also touches on regulatory challenges, the role of AI in supporting pathologists rather than replacing them, and the future of digital pathology in improving diagnostic efficiency and accuracy.

Conversation with Jukka Tapaninen, CEO at Aiforia Technologies2026-10-06T08:47:17+00:00

PathAI Announces PLUTO: a State-of-the-Art Foundation Model to Enhance AI-powered Pathology Tools

2024-05-14T15:36:59+00:00

Foundation models were developed on numerous diverse data and will enable drug discovery and anatomic pathology laboratory use cases

PathAI Announces PLUTO: a State-of-the-Art Foundation Model to Enhance AI-powered Pathology Tools2024-05-14T15:36:59+00:00

A Pathologist’s Perspective: Advantages Of Using FFPE Tissues For Single Cell Analysis

2025-06-26T16:08:13+00:00

How do pathologists approach critical questions of disease diagnosis? What tools help them move closer to a detailed understanding of the cellular processes that lead to disease? Traditionally, histological methods have driven diagnosis, but, in recent years, highly sensitive molecular assays—including single cell analysis—have begun to provide avenues for more in-depth profiling of tissue complexity. With these complementary methods, the field gains more potential to move toward personalized medicine.

A Pathologist’s Perspective: Advantages Of Using FFPE Tissues For Single Cell Analysis2025-06-26T16:08:13+00:00

How High-definition Spatial Transcriptomics, Single Cell FFPE, And Xenium Are Tackling The Cancer Problem Showcased At AACR 2024

2026-10-06T07:42:38+00:00

In her opening plenary session at AACR 2024, Aviv Regev, PhD, Head of Genentech Research and Early Development, pointed out the huge problem—indeed, the potentially overwhelming problem—of cancer. There are > 100 different cancer types, 10,000 known driver mutations, complex circuits driving cancer biology within and between cells in the tumor microenvironment, and an almost unfathomable number of possible small molecules and antibody structures to consider for drug development.

How High-definition Spatial Transcriptomics, Single Cell FFPE, And Xenium Are Tackling The Cancer Problem Showcased At AACR 20242026-10-06T07:42:38+00:00

Case Of The Month | May 2024 | Feline Eosinophilic Sclerosing Fibroplasia

2024-05-10T08:33:44+00:00

This is a section of ileum, where submucosa and tunica muscularis were almost entirely effaced by an extensive proliferation of irregular anastomosing trabeculae of collagen separated by numerous eosinophils and spindle cells, and fewer mast cells, histiocytes, neutrophils, lymphocytes and plasma cells. These findings are consistent with eosinophilic sclerosing fibroplasia. In this case was also observed in colon.

Case Of The Month | May 2024 | Feline Eosinophilic Sclerosing Fibroplasia2024-05-10T08:33:44+00:00

Fujifilm And Aws Combine For World’s First Fully Cloud-based Digital Pathology Solution At University Hospitals Of Leicester NHS Trust

2024-05-08T15:39:34+00:00

The global leader in Digital Pathology, Fujifilm Healthcare, are working in collaboration with fellow Healthcare technology provider, Amazon Web Services (AWS), to deliver a world first at the University Hospitals of Leicester NHS Trust. University Hospitals of Leicester NHS Trust is comprised of three separate sites, Leicester Royal Infirmary, Leicester General Hospital, and Glenfield Hospital, all of which are transforming their Pathology delivery and reducing diagnosis timelines through digitalisation.

Fujifilm And Aws Combine For World’s First Fully Cloud-based Digital Pathology Solution At University Hospitals Of Leicester NHS Trust2024-05-08T15:39:34+00:00

DigitCells Unveils Proprietary TWO-D system at AUA 2024, Revolutionizing Pathology Workflows

2024-05-03T11:36:25+00:00

DigitCells, a leading innovator in complete digital pathology solutions and a subsidiary company of GoPath Diagnostics, is excited to announce the launch of its groundbreaking Tissue Workflow Optimization for Digital (TWOD) system for prostate at the upcoming 2024 American Urological Association (AUA) Annual Meeting in San Antonio, Texas.

DigitCells Unveils Proprietary TWO-D system at AUA 2024, Revolutionizing Pathology Workflows2024-05-03T11:36:25+00:00

Aiosyn’s AI-powered Mitosis Detection Solution is Now Accessible in Sectra Amplifier Marketplace

2024-05-02T12:00:35+00:00

Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, has announced the integration of its innovative mitosis detection algorithm, Aiosyn Mitosis Breast*, with Sectra’s solution for digital pathology. It is now part of the Sectra Amplifier Marketplace. This allows pathology laboratories worldwide using Sectra’s solution to seamlessly incorporate Aiosyn Mitosis Breast into their existing workflow.

Aiosyn’s AI-powered Mitosis Detection Solution is Now Accessible in Sectra Amplifier Marketplace2024-05-02T12:00:35+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top